Portal de Periódicos da CAPES

Drug‐induced Sweet's syndrome

2004; Wiley; Volume: 18; Issue: 2 Linguagem: Inglês

10.1111/j.1468-3083.2004.00866.x

1468-3083

M Sáez, M. García‐Bustinduy, Anna H. Noda, S. Dorta, M. Escoda, E. Fagundo, F Rodríguez, Francisco Guimerá, R. Sánchez, R. García-Montelongo,

Vascular Malformations and Hemangiomas

Journal of the European Academy of Dermatology and VenereologyVolume 18, Issue 2 p. 233-233 Drug-induced Sweet's syndrome M Sáez, Corresponding Author M Sáez Department of Dermatology, Hospital Universitario de Canarias, University of La Laguna, 38320, La Laguna, Tenerife, Spain. *Corresponding author, C/Pilar n°19; 7°E, Santa Cruz de Tenerife, 38002, Tenerife, Spain, tel. +34 22 262649; fax +34 22 288205; E-mail: [email protected]Search for more papers by this authorM García-Bustínduy, M García-Bustínduy Department of Dermatology, Hospital Universitario de Canarias, University of La Laguna, 38320, La Laguna, Tenerife, Spain.Search for more papers by this authorA Noda, A Noda Department of Dermatology, Hospital Universitario de Canarias, University of La Laguna, 38320, La Laguna, Tenerife, Spain.Search for more papers by this authorS Dorta, S Dorta Department of Dermatology, Hospital Universitario de Canarias, University of La Laguna, 38320, La Laguna, Tenerife, Spain.Search for more papers by this authorM Escoda, M Escoda Department of Dermatology, Hospital Universitario de Canarias, University of La Laguna, 38320, La Laguna, Tenerife, Spain.Search for more papers by this authorE Fagundo, E Fagundo Department of Dermatology, Hospital Universitario de Canarias, University of La Laguna, 38320, La Laguna, Tenerife, Spain.Search for more papers by this authorF Rodríguez, Corresponding Author F Rodríguez Department of Dermatology, Hospital Universitario de Canarias, University of La Laguna, 38320, La Laguna, Tenerife, Spain. *Corresponding author, C/Pilar n°19; 7°E, Santa Cruz de Tenerife, 38002, Tenerife, Spain, tel. +34 22 262649; fax +34 22 288205; E-mail: [email protected]Search for more papers by this authorF Guimerá, F Guimerá Department of Dermatology, Hospital Universitario de Canarias, University of La Laguna, 38320, La Laguna, Tenerife, Spain.Search for more papers by this authorR Sánchez, R Sánchez Department of Dermatology, Hospital Universitario de Canarias, University of La Laguna, 38320, La Laguna, Tenerife, Spain.Search for more papers by this authorR García-Montelongo, R García-Montelongo Department of Dermatology, Hospital Universitario de Canarias, University of La Laguna, 38320, La Laguna, Tenerife, Spain.Search for more papers by this author M Sáez, Corresponding Author M Sáez Department of Dermatology, Hospital Universitario de Canarias, University of La Laguna, 38320, La Laguna, Tenerife, Spain. *Corresponding author, C/Pilar n°19; 7°E, Santa Cruz de Tenerife, 38002, Tenerife, Spain, tel. +34 22 262649; fax +34 22 288205; E-mail: [email protected]Search for more papers by this authorM García-Bustínduy, M García-Bustínduy Department of Dermatology, Hospital Universitario de Canarias, University of La Laguna, 38320, La Laguna, Tenerife, Spain.Search for more papers by this authorA Noda, A Noda Department of Dermatology, Hospital Universitario de Canarias, University of La Laguna, 38320, La Laguna, Tenerife, Spain.Search for more papers by this authorS Dorta, S Dorta Department of Dermatology, Hospital Universitario de Canarias, University of La Laguna, 38320, La Laguna, Tenerife, Spain.Search for more papers by this authorM Escoda, M Escoda Department of Dermatology, Hospital Universitario de Canarias, University of La Laguna, 38320, La Laguna, Tenerife, Spain.Search for more papers by this authorE Fagundo, E Fagundo Department of Dermatology, Hospital Universitario de Canarias, University of La Laguna, 38320, La Laguna, Tenerife, Spain.Search for more papers by this authorF Rodríguez, Corresponding Author F Rodríguez Department of Dermatology, Hospital Universitario de Canarias, University of La Laguna, 38320, La Laguna, Tenerife, Spain. *Corresponding author, C/Pilar n°19; 7°E, Santa Cruz de Tenerife, 38002, Tenerife, Spain, tel. +34 22 262649; fax +34 22 288205; E-mail: [email protected]Search for more papers by this authorF Guimerá, F Guimerá Department of Dermatology, Hospital Universitario de Canarias, University of La Laguna, 38320, La Laguna, Tenerife, Spain.Search for more papers by this authorR Sánchez, R Sánchez Department of Dermatology, Hospital Universitario de Canarias, University of La Laguna, 38320, La Laguna, Tenerife, Spain.Search for more papers by this authorR García-Montelongo, R García-Montelongo Department of Dermatology, Hospital Universitario de Canarias, University of La Laguna, 38320, La Laguna, Tenerife, Spain.Search for more papers by this author First published: 19 February 2004 https://doi.org/10.1111/j.1468-3083.2004.00866.xCitations: 27Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Su WPD, Liu HNH. Diagnostic criteria for Sweet's syndrome. Cutis 1986; 37: 167 – 170. CASPubMedWeb of Science®Google Scholar 2 Walker DC, Cohen PR. Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet's syndrome. J Am Acad Dermatol 1996; 34: 918 – 923. 10.1016/S0190-9622(96)90080-8 CASPubMedWeb of Science®Google Scholar 3 Tefany FJ, Georgouras K. A neutrophilic reaction of Sweet's syndrome type associated with the oral contraceptive. Australas J Dermatol 1991; 32: 55 – 59. 10.1111/j.1440-0960.1991.tb00684.x PubMedGoogle Scholar 4 Thibault MJ, Billick RC, Srolovitz H. Minocycline-induced Sweet's syndrome. J Am Acad Dermatol 1992; 27: 801 – 804. 10.1016/0190-9622(92)70251-A PubMedWeb of Science®Google Scholar 5 Takada S, Matumoto K, Sakura T et al. Sweet's syndrome followed by retinoic acid syndrome during the treatment of acute promyelocytic leukemia with all-trans retinoic acid. Int J Haematol 1999; 70: 26 – 29. CASPubMedWeb of Science®Google Scholar 6 Matsumura T, Kami M. Sweet's syndrome after granulocyte colony-stimulating factor administration for refractory myelodysplastic syndrome. Br J Haematol 2001; 113: 1. 10.1046/j.1365-2141.2001.02684.x CASPubMedWeb of Science®Google Scholar 7 Gilmour E, Chalmers RJG, Rowlands DJ. Drug-induced Sweet's syndrome (acute febrile netrophilic dermatosis) associated with hydralazine. Br J Dermatol 1995; 133: 490 – 491. 10.1111/j.1365-2133.1995.tb02686.x PubMedWeb of Science®Google Scholar 8 Ginarte M, García Doval I, Toribio J. Sweet's syndrome: a study of 16 cases. Med Clin (Barc) 1997; 109: 588 – 591. CASPubMedWeb of Science®Google Scholar 9 Sitjas D, Puig L, Cuatrecasas M, De Moragas JM. Acute febrile neutrophilic dermatosis (Sweet's syndrome). Int J Dermatol 1993; 32: 261 – 268. 10.1111/j.1365-4362.1993.tb04265.x CASPubMedWeb of Science®Google Scholar 10 Retief CR, Malkinson FD. Nitrofurantoin-associated Sweet's syndrome. Cutis 1999; 63: 177 – 179. CASPubMedWeb of Science®Google Scholar 11 Guimera FJ, Garcia-Bustínduy M, Noda A, Sáez M, Dorta S, Sanchez R et al. Diazepam-associated sweet's syndrome. Int J Dermatol 2000; 39: 795 – 798. 10.1046/j.1365-4362.2000.00051.x CASPubMedGoogle Scholar 12 Sáez M, Garcia-Bustínduy M, Noda A, Guimerá F, Dorta S, Escoda M et al. Sweet's syndrome induced by oral Contraceptive. Dermatology 2002; 204: 84. 10.1159/000051820 CASPubMedWeb of Science®Google Scholar Citing Literature Volume18, Issue2March 2004Pages 233-233 ReferencesRelatedInformation